【新型コロナウイルス対策ご協力のお願い:ご来院前に必ずご確認下さい】

医局(その他)

雑誌掲載論文一覧 2009年~

所属科執筆者名論文名雑誌名ページ
病理診断科

Tomoyuki Ohuchi

A rare case of Helicobacter pylori-uninfected intramucosal poorly differentiated adenocarcinoma that occurred in the gastric fornix

Clin J Gastroenterol

2020

Online
腫瘍内科

Hiroyuki Okuda

Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)

Target Oncol

2020155623-633
腫瘍内科

Hiroyuki Okuda

Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)

Eur J Cancer

2020135
11-21
腫瘍内科

Hiroyuki Okuda

An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect)

J Anus Rectum Colon

2020

4

279-84
腫瘍内科

Hiroyuki Okuda

A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)

Clin Colorectal Cancer

2020

19

113-21
病理診断科

Tomoyuki Ohuchi

Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma

Pathol Int

2021

71


113-123
泌尿器科

谷口明久

精巣漿膜を用いて代用膀胱直腸瘻閉鎖術を施行した1例

泌尿器外科

2019326869-871
腫瘍内科

Okuda H

First-line chemotherapy with S-1 alone or S-1plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study

Gastric Cancer

2018215792-801
腫瘍内科

Okuda H

First-line chemotherapy with S-1 alone or S-1plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study 

Gastric Cancer

2018215492-801
腫瘍内科

Okuda H

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase Ⅱ trial and biomarker study(WJOG7212G)

Gastric Cancer

201821184-95
腫瘍内科

Hiroyuki

Okuda

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastiric cancer: a phaseⅡ trial and biomarker study (WJOG7212G)

Gastric Cancer

2017

Online公開
腫瘍内科

Hiroyuki

Okuda

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics

Oncotarget

201781117810-17818
腫瘍内科

川上賢太郎

食道癌ー化学放射線療法

臨牀と研究

201794121-6
腫瘍内科

Hiroyuki

Okuda

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G

 Cancer Sci

2016107121843-1850
病理診断科大内知之唾液腺導管癌のup to date -病理組織学的事項を中心に-日本唾液腺学会誌2016 57
63-72
泌尿器科平川和志民間病院におけるダ・ヴィンチ導入の有用性と課題新医療2013403124-127
泌尿器科小林智治尿路系に発生した続発生悪性リンパ腫の2症例泌尿器外科20152871247-1251
病理診断科大内知之顎骨検体の取り扱い方 -切り出し、脱灰など-病理と臨床2013315486-491
麻酔科小村好弘片肺換気において麻酔薬がPaO2に与える影響-プロポフォールとイソフルランの比較日本臨床麻酔学会誌200020 97-100